Navigation Links
OHK Medical Devices to Exhibit at 2013 American Academy of Orthopedic Surgeons (AAOS) in Chicago
Date:2/28/2013

Chicago, IL (PRWEB) February 28, 2013

OHK Medical Devices Ltd., manufacturer of the HemaClear® single-use, sterile exsanguinating tourniquet device, announced today that it will be exhibiting at the 2013 American Academy of Orthopedic Surgeons (AAOS). The meeting will take place March 20th through the 22nd in Chicago. The company is excited to celebrate major clinical milestones and increase the presence of the growing tourniquet of choice.

In 2012 OHK Medical Devices celebrated the 500,000 application of HemaClear®. Further, it celebrated the successful launch of HemaClear® in multiple countries including Australia, France and South Korea.

“We are very excited to showcase our tourniquet technology at the AAOS. The conference provides a unique opportunity to introduce surgeons to the first innovation in the field in over a century" said Omer Inbar, VP of Sales, OHK Medical Devices. Mr. Inbar added that “After a very strong year in 2012, we are off to a fantastic start in 2013 as HemaClear sales continue to take off. Our current expansion efforts combine creating a presence in new markets such as Latin America, Eastern Europe and Scandinavia and deepening our footprint in the existing markets in Europe and the US.”

OHK Medical Devices will be exhibiting in the main hall of the McCormick Center booth #1108. Surgeons and industry professionals are urged to come by the booth and learn why HemaClear® is quickly becoming the global tourniquet of choice.

About HemaClear®
HemaClear® is the world’s leading sterile tourniquet with a simple yet innovative technology, representing a new standard of care in bloodless orthopedic surgery. Since entering the market in 2007 this product has been successfully used in almost 500,000 procedures. Easier, cheaper and safer than the standard offerings, HemaClear® represents the first significant advancement in tourniquet technology in over 100 years. HemaClear® was developed by OHK Medical Devices (OHK), a privately held company based in Haifa, Israel and the United States and is currently used in over 2000 operating rooms across 30 countries. For more information about HemaClear®, visit http://www.hemaclear.com.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10472923.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Clinovo, Leading CRO in the Bay Area, Endorsed by Medical Device Company for Their Flagship System: Clincapture
2. IpAuctions™, Inc. "All Things Medical" Auction event is opening March, 2013.
3. Foundation for the NIH Announces Lurie Prize Recognizing Outstanding Achievement by a Young Biomedical Scientist
4. Palomar Medical Center in San Diego County Introduces New Wrist-Worn Wireless Patient Vital Signs Device
5. Quantason Names Dr. Ellen B. Mendelson, Medical Director
6. R&D, Innovation Key to Success - Research Report on Varian Medical Systems, Inc., Boston Scientific Corporation, Stryker Corporation, St. Jude Medical, Inc., and Thermo Fischer Scientific Inc.
7. Vista College Introduces Its New Medical Laboratory Technician Diploma Program At El Paso Campus
8. Vermillion to Participate in Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference on February 27, 2013
9. Nasseo, Inc. Joins BioInspire™ Medical Technology Incubator, Closes Seed Funding Round
10. University of Colorado Cancer Center Study Shows the Preferred Feeding Method is not the Medically Best in Malnourished Pediatric Cancer Patients
11. Bluestar Silicones Presents Soft Silicone Advantages At Medical Design And Manufacturing (MD&M) West Show
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... As Ebola resurfaces in the Democratic Republic of ... now reported, a new analysis of the Ebola gene polymerase ... the 2014 and 2017 outbreaks of the disease.  ... preceded the 2014 outbreak. An analysis of the latest data ... 2014-15, which again precedes the current outbreak in the DRC. ...
(Date:5/23/2017)... , ... May 23, 2017 , ... A recent survey ... most troublesome and difficult to control weed in 12 categories of broadleaf crops, fruits ... 200 weed scientists across the U.S. and Canada participated in the 2016 survey, the ...
(Date:5/23/2017)... Basel, Switzerland (PRWEB) , ... May 23, 2017 ... ... for R&D, celebrates this month its 20th anniversary, marking the occasion with a ... is sponsoring the meeting’s Welcome Reception and further extends an invitation to all ...
(Date:5/23/2017)... BELLINGHAM, Washington, USA (PRWEB) , ... May 22, ... ... SPIE Optics and Photonics 2017 in San Diego, California, this August ... virtual reality, solar fuels, and autonomous vehicles. , SPIE Optics and Photonics, the ...
Breaking Biology Technology:
(Date:4/17/2017)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), ... Report on Form 10-K on Thursday April 13, 2017 with the ... The ... section of the Company,s website at http://www.nxt-id.com  under "SEC Filings," ... 2016 Year Highlights: Acquisition of ...
(Date:4/13/2017)... 13, 2017 According to a new market research ... Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and ... is expected to grow from USD 14.30 Billion in 2017 to USD ... 17.3%. ... MarketsandMarkets Logo ...
(Date:4/11/2017)... DUBLIN , Apr. 11, 2017 Research ... Tracking Market 2017-2021" report to their offering. ... The global eye tracking market to grow at ... The report, Global Eye Tracking Market 2017-2021, has been prepared based ... report covers the market landscape and its growth prospects over the ...
Breaking Biology News(10 mins):